Sulfonyl hydrazines as hypoxia-selective antineoplastic agents

Details for Australian Patent Application No. 2005286833 (hide)

Owner Vion Pharmaceuticals, Inc.

Inventors King, Ivan; Belcourt, Michael F.; Lin, Xu; Doyle, Terrence W.

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-B-2005286833

PCT Pub. Number WO2006/034266

Priority 60/611,623 21.09.04 US; 60/616,500 06.10.04 US; 60/615,419 01.10.04 US

Filing date 21 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 16 February 2012

International Classifications

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/034266 Priority application(s): WO2006/034266

16 February 2012 Application Accepted

  Published as AU-B-2005286833

24 May 2012 Assignment before Grant

  Vion Pharmaceuticals, Inc. The application has been assigned to Nanotherapeutics, Inc. 2006

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286840-Tissue expansion devices

2005286831-Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated DNA analysis